Ignite Creation Date:
2024-07-17 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499675
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery a Biopsy-based Study
Sponsor:
Egyptian Liver Hospital
Organization:
Egyptian Liver Hospital
Study Overview
Official Title:
Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery a Biopsy-based Study
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the prevalence of steatosis steatohepatitis and their associated risk factors in obese patients undergoing bariatric surgery
Detailed Description:
A prospective single-center biopsy-based study was conducted on 162 sleeve gastrectomy patients Patient characteristics including age sex diabetes mellitus DM status body mass index BMI liver function tests lipogram homeostatic model assessment of insulin resistance HOMA-IR and steatosis were also assessed using controlled attenuation parameter CAP and intra operative liver biopsies were obtained The presence of steatosis and steatohepatitis were histologically assessed by two expert pathologists
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None